Liver Diseases, Alcoholic: Clinical Trials

207 trials for Liver Diseases, Alcoholic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

92 completed, 39 unknown, 35 recruiting, 17 terminated. 54 Not applicable, 40 Phase 2, 26 Phase 3, 11 Phase 4, 8 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable54Completed 22, Recruiting 12, Unknown 10, Not yet recruiting 4, Terminated 4, Active not recruiting 2
Phase 240Completed 21, Recruiting 6, Terminated 6, Unknown 3, Not yet recruiting 2, Withdrawn 2
Phase 326Completed 12, Recruiting 5, Unknown 4, Terminated 3, Active not recruiting 1, Withdrawn 1
Phase 411Unknown 6, Completed 4, Terminated 1
Phase 18Completed 4, Unknown 3, Terminated 1
Early Phase 14Completed 2, Recruiting 1, Withdrawn 1

Follow Liver Diseases, Alcoholic: new trials by email Literature Review of Liver Diseases, Alcoholic trials Research Report on Liver Diseases, Alcoholic

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pomegranate Dietary Supplements in AUD and ALD
Pomegranate Dietary Ssupplement - Alcohol Use Disorder, Alcohol-associated Liver Disease
Not yet recruitingUniversity of Louisville1442027-01-012026-07-24
Inflammatory and Neuroimmune Guided Investigation of Underlying Fatigue in Patients With Cirrhosis
Cirrhosis Alcoholic, Fatigue Symptom
Not yet recruitingKing's College London502027-01-012026-10-27
Elastography-based Brief Alcohol Intervention in Hospitalized Individuals
Elastography-based brief alcohol intervention - Alcoholic Liver Disease (ALD), Alcohol Use Disorder
Not applicableRecruitingOslo University Hospital5002026-09-142026-10-22
A Study to Investigate the Safety and Efficacy of Efimosfermin Alfa Compared With Placebo in Adult Participants With Alcohol-related Liver Disease (ALD)
Efimosfermin alfa, Placebo - Liver Diseases, Alcoholic
Phase 2RecruitingGlaxoSmithKline2742026-08-312026-09-30
Financial Rewards for Reducing Alcohol Use in Patients With Liver Disease
PEth Based Contingency Management, PEth Monitoring with Fixed Incentives - Alcohol Use Disorder, Alcohol-associated Liver Disease
Not applicableNot yet recruitingMassachusetts General Hospital902026-08-012026-03-12
A-TANGO Phase 2 Study
Placebo, TAK-242, G-CSF (Filgrastim) - Acute-On-Chronic Liver Failure, Alcoholic Hepatitis
Phase 2RecruitingYaqrit Ltd782026-06-292026-09-21
PROlonged Corticosteroid Treatment or N-ACetylcysteine for Severe Alcoholic Hepatitis
N-Acetylcysteine (NAC) Treatment, Prednisolone, Placebo of N-acetylcysteine - Alcoholic Hepatitis
Phase 3RecruitingUniversity Hospital, Lille4772026-05-222026-06-01
The Efficacy of Tocotrienol Rich Fraction for Liver Protection in Adult Patients With Alcoholic Fatty Liver Disease (AFLD)
Palm Tocotrienol Rich Fraction (TRF), Refined, bleached, and deodorised (RBD) palm olein - Alcoholic Fatty Liver Disease
Phase 2Not yet recruitingUniversiti Kebangsaan Malaysia Medical Centre262026-05-022026-04-29
Personalized Transcranial Magnetic Stimulation (TMS) for Metabolic Dysfunction and Alcohol-Related Liver Disease
Individually Targeted rTMS, Conventional rTMS, Transcranial Magnetic Stimulation Sham - Liver Diseases, Alcoholic, Fatty Liver
Not applicableNot yet recruitingThe Affiliated Hospital of Hangzhou Normal University1052026-02-012026-02-10
Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)
Larsucosterol, Placebo - Hepatitis
Phase 3RecruitingBausch Health Americas, Inc.3502026-01-292026-10-15
Alcohol Consumption and Plasma cfDNA Methylation in Chronic Hepatitis B
Alcohol Consumption - Chronic Hepatitis B, Alcoholic Hepatitis
CompletedBeijing Municipal Administration of Hospitals852025-11-212026-10-08
Alcohol Misuse Treatment to Patients Newly Diagnosed With Alcohol-related Liver Disease: a Randomized Controlled Trial
Offer of specialized alcohol use disorder treatment in the hepatology clinic - Liver Diseases, Alcoholic, Alcohol Use Disorder
Not applicableRecruitingZealand University Hospital2212025-11-152025-11-18
LiverTREM-1: Hepatic TREM-1 Expression and Prognosis in Severe Alcoholic Hepatitis
TREM-1 expression (via immunohistochemistry) between SAH patients and controls - Severe Alcoholic Hepatitis
Not yet recruitingCentral Hospital, Nancy, France3002025-10-012025-09-16
Health Literacy and Self-efficacy Expectations in Patients With Alcohol-related Liver Cirrhosis
Self-Efficacy, Health Literacy
RecruitingHannover Medical School2002025-08-112025-09-11
Gepaktiv vs UDCA and Ademetionine in MAFLD With Hepatomegaly
Dietary supplement "Gepaktiv", UDCA (Ursodeoxycholic acid), Ademetionine - Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD), Hepatomegaly
Not applicableRecruitingPhenomen Pharma902025-06-192025-07-23
Investigating HepQuant DuO Test as a Biomarker in Alcohol-related Liver Disease
HepQuant DuO Test - Alcoholic Hepatitis, Alcohol-related Liver Disease
RecruitingHepQuant, LLC402025-06-102026-09-16
Long-term Follow-up to Determine Outcome in Liver Disease (LOVE Study)
Steatotic Liver Disease, MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)
Not yet recruitingUniversität des Saarlandes300002025-04-152025-04-02
Short Course Steroids in Alcohol Associated Hepatitis
Prednisolone 40 mg - Alcoholic Hepatitis
Phase 3CompletedAsian Institute of Gastroenterology, India1512025-04-072026-09-01
Randomized Controlled Trial of Mycophenolate Mofetil Versus Steroid Therapy in Alcoholic Hepatitis
Mycophenolate Mofetil, Prednisone - Alcoholic Hepatitis
Not applicableNot yet recruitingInstitute of Liver and Biliary Sciences, India602025-01-202025-01-23
Nutritional Interventions in Patients With Alcohol-associated Hepatitis
Nutritional supplement - Alcoholic Hepatitis
Not applicableUnknownWestern University, Canada20002025-01-012024-05-29

Showing 20 of 207. Sign in to see all of them.

Narrower conditions

Hepatitis, Alcoholic (108)  ·  Liver Cirrhosis, Alcoholic (44)  ·  Fibrosis (28)  ·  Alcoholism (24)  ·  Liver Cirrhosis (23)  ·  Liver Diseases (17)  ·  Non-alcoholic Fatty Liver Disease (13)  ·  Hepatitis (8)  ·  Carcinoma, Hepatocellular (7)  ·  Fatty Liver (6)  ·  Fatty Liver, Alcoholic (6)  ·  Infections (6)  ·  Liver Failure (5)  ·  Ascites (4)

Broader conditions

Chemically-Induced Disorders (207)  ·  Substance-Related Disorders (207)  ·  Digestive System Diseases (206)  ·  Alcohol-Induced Disorders (205)  ·  Alcohol-Related Disorders (204)  ·  Liver Diseases (190)  ·  Hepatitis (108)  ·  Pathological Conditions, Signs and Symptoms (86)  ·  Pathologic Processes (85)  ·  Fibrosis (48)  ·  Liver Cirrhosis (40)  ·  Mental Disorders (26)  ·  Infections (15)  ·  Fatty Liver (13)

Interventions

Prednisolone (11)  ·  Granulocyte Colony-Stimulating Factor (7)  ·  Pentoxifylline (7)  ·  Acetylcysteine (6)  ·  Ethanol (6)  ·  Blood Specimen Collection (5)  ·  Fecal Microbiota Transplantation (5)  ·  Liver Transplantation (4)  ·  Prednisone (4)  ·  Probiotics (4)  ·  Standard of Care (4)  ·  Adrenal Cortex Hormones (3)  ·  Baclofen (3)  ·  Methylprednisolone (3)  ·  S-Adenosylmethionine (3)

Sponsors

Institute of Liver and Biliary Sciences, India (11)  ·  Erasme University Hospital (7)  ·  University Hospital, Lille (7)  ·  Assistance Publique - Hôpitaux de Paris (6)  ·  The Cleveland Clinic (6)  ·  University of Aarhus (6)  ·  Chuncheon Sacred Heart Hospital (5)  ·  Indiana University (5)  ·  Pharmicell Co., Ltd. (5)  ·  Post Graduate Institute of Medical Education and Research, Chandigarh (5)  ·  Asian Institute of Gastroenterology, India (3)  ·  Copenhagen University Hospital, Hvidovre (3)  ·  University Hospital, Montpellier (3)  ·  University of Alabama at Birmingham (3)  ·  University of Pittsburgh (3)

Countries

United States (66)  ·  France (31)  ·  India (23)  ·  United Kingdom (18)  ·  Denmark (17)  ·  South Korea (14)  ·  Belgium (10)  ·  China (7)  ·  Germany (6)  ·  Spain (6)  ·  Canada (4)  ·  Italy (4)  ·  Australia (3)  ·  Mexico (3)  ·  Zambia (3)

Top investigators

Michael J Vinikoor, MD (3)  ·  Arnaud Lemmers, MD (2)  ·  Christophe Moreno, MD, PhD (2)  ·  Craig J McClain, MD (2)  ·  Ki Tae Suk, PhD (2)  ·  Moonyoung Kim (2)  ·  Naga Chalasani, MD (2)  ·  Philippe Mathurin, MD,PhD (2)  ·  Robert S Brown, MD, MPH (2)  ·  Santiago Tome, MD (2)  ·  Soon Koo Baik, M.D.,Ph.D (2)  ·  Srinivasan Dasarathy, MD (2)  ·  . Prasanna Samuel Premkumar, PhD (1)  ·  Abigail Smith (1)  ·  Abigail Smith, PhD (1)

Results publications

PMID 37011138, PMID 16026887, PMID 19553649, PMID 31811953, PMID 35084335, PMID 38215876, PMID 10782906, PMID 11113085, PMID 11172350, PMID 11605686, PMID 11943418, PMID 14647046, PMID 14653766, PMID 15122768, PMID 1531090, PMID 15349802, PMID 15618643, PMID 15763232, PMID 16009691, PMID 17204261, PMID 17518367, PMID 18068515, PMID 18270828, PMID 1828447, PMID 18721242, PMID 19058754, PMID 19177575, PMID 19340904, PMID 19445945, PMID 19560604, PMID 19821406, PMID 20334708, PMID 20561703, PMID 21085006, PMID 21334404, PMID 2142869, PMID 22044287, PMID 22070475, PMID 22388710, PMID 22633836, PMID 22821948, PMID 23029716, PMID 23101983, PMID 2358784, PMID 23737845, PMID 23782511, PMID 23855300, PMID 23870864, PMID 23939511, PMID 24026598

NIH funding

P50AA027054 (2), U01AA021788 (2), U01AA021840 (2), U01AA021886 (2), U01AA021891 (2), U01AA021893 (2), U24DK130164 (2), 2004 (1), 2014 (1), 2016 (1), 2025 (1), K01TW009998 (1), K23AA018399 (1), P50AA024337 (1), R01AA014562 (1)